Grimes & Company’s Danaher DHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
7,017
-6,804
-49% -$1.24M 0.03% 225
2026
Q1
$2.62M Buy
13,821
+521
+4% +$111K 0.07% 158
2025
Q4
$3.04M Buy
13,300
+5,599
+73% +$1.23M 0.07% 153
2025
Q3
$1.53M Buy
7,701
+16
+0.2% +$3.18K 0.04% 200
2025
Q2
$1.52M Buy
7,685
+163
+2% +$31.6K 0.04% 178
2025
Q1
$1.54M Buy
7,522
+132
+2% +$28.8K 0.05% 157
2024
Q4
$1.7M Buy
7,390
+43
+0.6% +$10.6K 0.05% 163
2024
Q3
$2.04M Buy
7,347
+5
+0.1% +$1.32K 0.06% 144
2024
Q2
$1.83M Sell
7,342
-2
-0% -$505 0.05% 139
2024
Q1
$1.83M Buy
7,344
+7
+0.1% +$1.71K 0.06% 141
2023
Q4
$1.7M Sell
7,337
-476
-6% -$101K 0.06% 142
2023
Q3
$1.72M Sell
7,813
-63
-0.8% -$14.1K 0.07% 133
2023
Q2
$1.68M Buy
7,876
+38
+0.5% +$8.04K 0.06% 134
2023
Q1
$1.75M Buy
7,838
+88
+1% +$20K 0.07% 121
2022
Q4
$1.82M Buy
7,750
+5
+0.1% +$1.16K 0.08% 129
2022
Q3
$1.77M Sell
7,745
-99
-1% -$24.2K 0.09% 113
2022
Q2
$1.76M Sell
7,844
-107
-1% -$24.6K 0.09% 116
2022
Q1
$2.07M Sell
7,951
-9
-0.1% -$2.25K 0.11% 118
2021
Q4
$2.32M Sell
7,960
-226
-3% -$62.2K 0.11% 115
2021
Q3
$2.21M Buy
8,186
+35
+0.4% +$9.53K 0.1% 111
2021
Q2
$1.94M Sell
8,151
-11
-0.1% -$2.44K 0.08% 115
2021
Q1
$1.63M Buy
8,162
+926
+13% +$188K 0.08% 115
2020
Q4
$1.43M Sell
7,236
-34
-0.5% -$6.82K 0.07% 122
2020
Q3
$1.39M Buy
7,270
+5
+0.1% +$889 0.09% 115
2020
Q2
$1.14M Hold
7,265
0.08% 117
2020
Q1
$891K Hold
7,265
0.08% 119
2019
Q4
$989K Hold
7,265
0.06% 132
2019
Q3
$930K Sell
7,265
-150
-2% -$18.8K 0.07% 131
2019
Q2
$940K Buy
7,415
+106
+1% +$12.6K 0.07% 127
2019
Q1
$855K Sell
7,309
-654
-8% -$67K 0.07% 122
2018
Q4
$728K Hold
7,963
0.07% 124
2018
Q3
$767K Buy
7,963
+621
+8% +$56.6K 0.06% 134
2018
Q2
$642K Sell
7,342
-57
-0.8% -$5.08K 0.06% 142
2018
Q1
$642K Buy
+7,399
New +$647K 0.06% 135

Other funds holding DHR

Grimes & Company's DHR Position: Q2 2026 in Review

Grimes & Company reduced its Danaher (DHR) stake by 49% in Q2 2026, selling an estimated $1.24M and leaving 7,017 shares worth $1.34M. The position accounts for 0.03% of the portfolio, ranked #225.

Grimes & Company first reported a position in DHR in Q1 2018 and has held it in 34 quarters since. The position peaked at $3.04M in Q4 2025. 857 funds tracked by Wall St. Rank hold DHR as of Q2 2026.

  • Grimes & Company held 7,017 shares of Danaher worth $1.34M as of Q2 2026.
  • Grimes & Company sold 6,804 Danaher shares in Q2 2026, an estimated $1.24M.
  • Danaher made up 0.03% of Grimes & Company's portfolio in Q2 2026, its #225 holding.
  • Grimes & Company first reported a position in Danaher in Q1 2018 and has held it in 34 quarters since.
  • Grimes & Company's Danaher position peaked at $3.04M in Q4 2025.
  • 857 funds tracked by Wall St. Rank held Danaher as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.